Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Mishra Meza A"'
Autor:
Salz, Talya, Mishra Meza, Akriti, Moryl, Natalie, Kriplani, Anuja, Tringale, Kathryn Ries, Flory, James, Bradshaw, Patrick T, Jinna, Sankeerth, Lipitz-Snyderman, Allison
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p366-366, 7p
Autor:
Lapen, Kaitlyn, Mishra Meza, Akriti, Dee, Edward Christopher, Mao, Jun J, Raghunathan, Nirupa Jaya, Jinna, Sankeerth, Brens, Jessica, Korenstein, Deborah, Furberg-Barnes, Helena, Salz, Talya, Chino, Fumiko
Publikováno v:
Journal of the National Cancer Institute. Monographs; August 2024, Vol. 2024 Issue: 66 p305-312, 8p
Autor:
Mitchell, Aaron P., Nemirovsky, David, Mishra Meza, Akriti, Chakraborty, Nirjhar, Persaud, Sonia, Farooki, Azeez, Morris, Michael J.
Publikováno v:
JCO Oncology Practice; Mar2024, Vol. 20 Issue 3, p393-400, 8p
Autor:
Aaron P. Mitchell, Akriti Mishra Meza, Katherine S. Panageas, Allison Lipitz-Snyderman, Azeez Farooki, Michael J. Morris
Publikováno v:
Prostate Cancer and Prostatic Diseases. 26:126-132
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation
Autor:
Angela K. Green, Sara M. Tabatabai, Xing Bai, Akriti Mishra Meza, Anne-Marie Lesny, Carol Aghajanian, Ola Landgren, Gregory J. Riely, Paul Sabbatini, Andrew Salner, Scott Lipkin, Andrew Ip, Peter B. Bach, Colin B. Begg, Sham Mailankody, Allison Lipitz-Snyderman
Publikováno v:
JAMA network open. 5(3)
The Centers for MedicareMedicaid Services requires health care organizations to report the National Clinical Trial (NCT) identifier on claims for items and services related to clinical trials that qualify for coverage. This same NCT identifier is use
Autor:
Talya Salz, Akriti Mishra Meza, Fumiko Chino, Jun J. J. Mao, Nirupa Jaya Raghunathan, Sankeerth Jinna, Jessica Brens, Maribel Hernandez, Deborah Korenstein
Publikováno v:
Journal of Clinical Oncology. 40:299-299
299 Background: Cannabis is increasingly legal and available to cancer patients, but the pattern of cannabis use among cancer patients is unknown. We aimed to characterize cannabis use patterns and beliefs among subgroups of cancer patients. Methods:
Autor:
Fumiko Chino, Akriti Mishra Meza, Jun J. J. Mao, Nirupa Jaya Raghunathan, Sankeerth Jinna, Jessica Brens, Maribel Hernandez, Deborah Korenstein, Talya Salz
Publikováno v:
Journal of Clinical Oncology. 40:24-24
24 Background: Cannabis is increasingly used by patients with cancer for symptom management but is not covered by insurance and may represent a significant financial burden. We assessed costs of cannabis products for patients who used at any time dur
Autor:
Aaron Philip Mitchell, Akriti Mishra Meza, Azeez Farooki, Katherine Panageas, Peter B. Bach, Allison Lipitz-Snyderman, Michael J. Morris
Publikováno v:
Journal of Clinical Oncology. 40:55-55
55 Background: Bone modifying agents (BMAs) prevent skeletal related events (SREs) among patients with metastatic, castrate-resistant prostate cancer (mCRPC) involving the bone. The utilization of BMAs among patients with mCRPC and bone metastasis ha
Autor:
Mitchell, Aaron P, Meza, Akriti Mishra, Panageas, Katherine S, Lipitz-Snyderman, Allison, Bach, Peter B, Morris, Michael J, Mishra Meza, Akriti
Publikováno v:
JNCI: Journal of the National Cancer Institute; Mar2022, Vol. 114 Issue 3, p419-426, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.